EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pilonidal sinus disease carcinoma: Survival and recurrence analysis

Mhd Firas Safadi, Konstantinos Degiannis, Dietrich Doll

Journal of Surgical Oncology · 2023-09 · 128 (4) · 569-575

DOI: 10.1002/jso.27319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 17.05.2023. Verfasst von Mhd Firas Safadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Visceral, Thoracic, and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Skin Neoplasms, Pilonidal Sinus. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The study aims to determine the survival and recurrence rates of pilonidal sinus disease (PSD) carcinoma.

Methods

The data were collected retrospectively by searching the worldwide literature for all reports of carcinoma developing on the background of PSD. The results were presented using Kaplan–Meier curves.

Results

Between 1900 and 2022, 140 cases of PSD carcinoma were published in 103 papers, with follow‐up data available in 111 cases. Squamous cell carcinoma constituted 94.6% of the cases ( n = 105). The disease‐specific survival rate was 61.7% for 3 years, 59.8% for 5 years, and 53.2% for 10 years. There was a significant survival difference between stages: 80.0% in stages I and II, 70.8% in stage III, and 47.8% in stage IV ( p = 0.01). The 5‐year survival in G1‐tumors was better than G2 and G3‐tumors at 70.5% and 32.0%, respectively ( p = 0.002). Recurrence occurred in 46.6% of the patients. The time‐to‐recurrence in patients treated with curative intention averaged 15.1 months (1–132 months). Local, regional, and distant recurrence was observed in 75.6%, 33.3%, and 28.9% of the recurrent tumors, respectively.

Conclusions

Pilonidal sinus carcinoma has a worse prognosis than primary cutaneous squamous cell carcinoma. Poor prognostic factors include advanced‐stage disease and poor differentiation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Squamous CellSkin NeoplasmsPilonidal SinusHumansRetrospective StudiesPrognosisRecurrence

Stichwörter der Autor:innen

Marjolin's ulcerinfection degenerationpilonidal sinus carcinomapilonidal sinus diseasesquamous cell carcinomasurvival analysis

Autor:innen und Institutionen

  • Department of Visceral, Thoracic, and Vascular Surgery, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
  • Vechtaer Institut für Forschungsförderung, VIFF e.V., Vechta, Germany.
  • Department of Trauma, Hand and Reconstructive Surgery, University Hospital of Saarland, University of Saarland, Homburg, Germany.
  • Department of Procto-Surgery and Pilonidal Sinus, St. Marienhospital Vechta, Academic Teaching Hospital of the MHH Hannover, Vechta, Germany.

Zitieren

APA

Safadi, M. F., Degiannis, K., & Doll, D. (2023). Pilonidal sinus disease carcinoma: Survival and recurrence analysis. Journal of Surgical Oncology, 128(4), 569-575. https://doi.org/10.1002/jso.27319

Vancouver

Safadi MF, Degiannis K, Doll D. Pilonidal sinus disease carcinoma: Survival and recurrence analysis. Journal of Surgical Oncology. 2023;128(4):569-575. doi:10.1002/jso.27319

BibTeX
@article{Safadi2023,
  author = {Safadi, Mhd Firas and Degiannis, Konstantinos and Doll, Dietrich},
  title = {Pilonidal sinus disease carcinoma: Survival and recurrence analysis},
  journal = {Journal of Surgical Oncology},
  year = {2023},
  volume = {128},
  number = {4},
  pages = {569--575},
  doi = {10.1002/jso.27319}
}
Kostenlos starten →